SI9720044B - Imunološka metoda detekcije protiteles proti tkivni transglutaminazi (tTG), uporaba tkivne transglutaminaze v diagnosticiranju in nadziranju terapije in oralna farmacevtska zmes, ki vsebuje tkivno transglutaminazo - Google Patents

Imunološka metoda detekcije protiteles proti tkivni transglutaminazi (tTG), uporaba tkivne transglutaminaze v diagnosticiranju in nadziranju terapije in oralna farmacevtska zmes, ki vsebuje tkivno transglutaminazo Download PDF

Info

Publication number
SI9720044B
SI9720044B SI9720044A SI9720044A SI9720044B SI 9720044 B SI9720044 B SI 9720044B SI 9720044 A SI9720044 A SI 9720044A SI 9720044 A SI9720044 A SI 9720044A SI 9720044 B SI9720044 B SI 9720044B
Authority
SI
Slovenia
Prior art keywords
ttg
tissue
diagnosis
therapy control
immunologically reactive
Prior art date
Application number
SI9720044A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9720044A (sl
Inventor
Detlef Schuppan
Walburga Dieterich
Tobias Ehnis
Original Assignee
Detlef Schuppan
Walburga Dieterich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7801172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9720044(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Detlef Schuppan, Walburga Dieterich filed Critical Detlef Schuppan
Publication of SI9720044A publication Critical patent/SI9720044A/sl
Publication of SI9720044B publication Critical patent/SI9720044B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
SI9720044A 1996-07-18 1997-07-14 Imunološka metoda detekcije protiteles proti tkivni transglutaminazi (tTG), uporaba tkivne transglutaminaze v diagnosticiranju in nadziranju terapije in oralna farmacevtska zmes, ki vsebuje tkivno transglutaminazo SI9720044B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19630557A DE19630557C2 (de) 1996-07-18 1996-07-18 Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
PCT/EP1997/003740 WO1998003872A2 (de) 1996-07-18 1997-07-14 IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG

Publications (2)

Publication Number Publication Date
SI9720044A SI9720044A (sl) 1999-08-31
SI9720044B true SI9720044B (sl) 2003-02-28

Family

ID=7801172

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9720044A SI9720044B (sl) 1996-07-18 1997-07-14 Imunološka metoda detekcije protiteles proti tkivni transglutaminazi (tTG), uporaba tkivne transglutaminaze v diagnosticiranju in nadziranju terapije in oralna farmacevtska zmes, ki vsebuje tkivno transglutaminazo

Country Status (21)

Country Link
US (2) US6319726B1 (cs)
EP (1) EP0912898B1 (cs)
CN (1) CN1138146C (cs)
AT (1) ATE210296T1 (cs)
AU (1) AU718797B2 (cs)
BR (1) BR9710500B1 (cs)
CA (1) CA2260769C (cs)
CZ (1) CZ291662B6 (cs)
DE (2) DE19630557C2 (cs)
DK (1) DK0912898T3 (cs)
ES (1) ES2131038T3 (cs)
GR (1) GR990300020T1 (cs)
HU (1) HU228479B1 (cs)
IL (1) IL128042A (cs)
NO (1) NO321466B1 (cs)
NZ (1) NZ333744A (cs)
PL (1) PL189091B1 (cs)
PT (1) PT912898E (cs)
SI (1) SI9720044B (cs)
SK (1) SK284410B6 (cs)
WO (1) WO1998003872A2 (cs)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999056698A2 (en) * 1998-05-06 1999-11-11 Københavns Universitet Treatment of celiac disease
JP2003521677A (ja) * 1999-06-28 2003-07-15 イムーンデイアグノステイツク・アー・ゲー グルテン過敏性腸疾患と他の自己免疫疾患の診断
CA2387359A1 (en) * 1999-10-20 2001-04-26 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
US6703208B1 (en) 1999-10-20 2004-03-09 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
CU22968A1 (es) * 2000-06-07 2004-07-14 Ct Ingenieria Genetica Biotech Procedimiento para la detección de anticuerpos anti transglutaminasa con utilidad en el diagnóstico de la enfermedad celíaca
GB0103024D0 (en) * 2001-02-07 2001-03-21 Rsr Ltd Assay for Autoantibodies to tissue transglutaminase
FI20010868A0 (fi) 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
KR100488131B1 (ko) * 2001-07-07 2005-05-06 (주)푸드바이오테크 알레르기 진단용 단백질 칩과 알레르기 유발원의 검출방법 및 알레르기 유발 항체의 검출 방법
GB0117870D0 (en) 2001-07-21 2001-09-12 Univ Nottingham Trent Method of diagnosis and kit of parts therefor
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
DK1572127T4 (da) * 2002-02-14 2014-11-24 Univ Leland Stanford Junior Enzymbehandling af fødevarer til cøliaki
US8143210B2 (en) * 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
RU2234086C2 (ru) * 2002-05-08 2004-08-10 Нижегородский научно-исследовательский институт детской гастроэнтерологии Способ дифференциальной диагностики целиакии и хронического энтерита у детей с патологией тонкой кишки
US7265093B2 (en) * 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
CA2487247A1 (en) * 2002-05-14 2003-11-27 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
US7202216B2 (en) * 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
US7462688B2 (en) * 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
ATE554392T1 (de) * 2002-11-20 2012-05-15 Univ Leland Stanford Junior Diagnoseverfahren für sprue/zöliakie
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7534426B2 (en) * 2004-04-26 2009-05-19 The Board Of Trustees Of The Leland Stanford Junior University Glutenase enzyme assays
US7563864B2 (en) * 2004-04-26 2009-07-21 Celiac Sprue Research Foundation Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
US7628985B2 (en) * 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US20080038760A1 (en) * 2004-06-08 2008-02-14 Method For Decting Anti-Transglutaminase Antibodies Method for Detecting Anti-Transglutaminase Antibodies
US20090305303A1 (en) * 2006-07-25 2009-12-10 Cecile Besson Duvanel immunochromatography device for the diagnosis of diseases in a sample
DK2126582T3 (da) * 2007-01-26 2011-10-10 Ga Generic Assays Gmbh Fremgangsmåde til påvisning af antistoffer fra kropsvæsker via en immunreaktion med glykoprotein 2 (gp2) fra zymogene granula af pankreas til differentialdiagnose af inflammatoriske tarmsygdomme og kronisk pankreatitis
CA2680590C (en) * 2007-03-16 2017-10-17 Jonathan David Gass Combination enzyme therapy for digestion of dietary gluten
EP1978364B1 (en) 2007-04-06 2011-06-01 Zedira GmbH Transglutaminase 6 as a diagnostic indicator of autoimmune diseases
HU0900199D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis of gluten-induced autoimmune diseases
FR2949782B1 (fr) 2009-09-04 2015-10-16 Isp Investments Inc Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant.
EP2812344A4 (en) 2012-02-07 2015-10-28 Vibrant Holdings Llc SUBSTRATES, PEPTIDE NETWORKS AND METHODS
DE102012007510A1 (de) 2012-04-17 2013-10-17 Aesku.Diagnostics GmbH & Co. KG Verfahren zur Präsymptomatischen Diagnostik von Zöliakie und Glutensensitivität
WO2013156156A1 (de) 2012-04-17 2013-10-24 Aesku.Diagnostics Gmbh & Co.Kg Verfahren zur präsymptomatischen diagnostik von zöliakie und glutensensitivität
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
EP4030167B1 (en) 2013-02-15 2025-05-14 Vibrant Holdings, LLC Methods and compositions for amplified electrochemiluminescence detection
CN104090102B (zh) * 2014-06-13 2016-08-17 江南大学 冷冻鱼糜中微生物谷氨酰胺转胺酶elisa检测方法
NZ730519A (en) 2014-09-10 2018-10-26 Vibrant Holdings Llc Peptide microarrays and novel biomarkers for celiac disease
US10538808B2 (en) 2017-05-26 2020-01-21 Vibrant Holdings, Llc Photoactive compounds and methods for biomolecule detection and sequencing
AU2019266303B2 (en) 2018-05-09 2025-12-18 Vibrant Holdings, Llc Methods of synthesizing a polynucleotide array using photactivated agents
CN110055235A (zh) * 2019-05-14 2019-07-26 深圳市亚辉龙生物科技股份有限公司 用于转谷氨酰胺酶抗体检测的抗原及其制备方法、试剂盒及检测方法
WO2025233646A2 (en) 2024-05-09 2025-11-13 Debreceni Egyetem Detection of celiac disease-specific autoantibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL155894B1 (en) * 1987-12-23 1992-01-31 Przed Zagraniczne W Polsce Pla Test for assessing gluten-dependent enteropathies
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
DE19520480C2 (de) 1995-06-03 1997-04-30 Univ Leipzig Immunochemisches Testmaterial und Enzymimmunoassay zur Diagnostik von Zöliakie und verwandten Eiweißintoleranzen
US5716794A (en) * 1996-03-29 1998-02-10 Xybernaut Corporation Celiac antigen

Also Published As

Publication number Publication date
IL128042A0 (en) 1999-11-30
EP0912898B1 (de) 2001-12-05
CN1138146C (zh) 2004-02-11
HK1021025A1 (en) 2000-05-26
GR990300020T1 (en) 1999-06-30
SI9720044A (sl) 1999-08-31
HUP0202779A3 (en) 2009-07-28
US20020076834A1 (en) 2002-06-20
SK6799A3 (en) 2000-05-16
DE19630557A1 (de) 1998-01-29
PT912898E (pt) 2002-05-31
CN1225723A (zh) 1999-08-11
AU4201197A (en) 1998-02-10
ES2131038T1 (es) 1999-07-16
NO990190L (no) 1999-03-15
ES2131038T3 (es) 2002-09-01
WO1998003872A3 (de) 1998-03-12
HUP0202779A2 (hu) 2002-12-28
US6319726B1 (en) 2001-11-20
AU718797B2 (en) 2000-04-20
HU228479B1 (en) 2013-03-28
BR9710500A (pt) 2000-01-18
WO1998003872A2 (de) 1998-01-29
NZ333744A (en) 2000-03-27
IL128042A (en) 2007-06-17
CA2260769C (en) 2005-09-06
ATE210296T1 (de) 2001-12-15
DE59705683D1 (de) 2002-01-17
PL331203A1 (en) 1999-07-05
DK0912898T3 (da) 2002-04-08
DE19630557C2 (de) 1998-07-02
EP0912898A2 (de) 1999-05-06
PL189091B1 (pl) 2005-06-30
CZ11799A3 (cs) 1999-07-14
NO990190D0 (no) 1999-01-15
CZ291662B6 (cs) 2003-04-16
NO321466B1 (no) 2006-05-15
CA2260769A1 (en) 1998-01-29
SK284410B6 (sk) 2005-03-04
BR9710500B1 (pt) 2009-05-05

Similar Documents

Publication Publication Date Title
SI9720044B (sl) Imunološka metoda detekcije protiteles proti tkivni transglutaminazi (tTG), uporaba tkivne transglutaminaze v diagnosticiranju in nadziranju terapije in oralna farmacevtska zmes, ki vsebuje tkivno transglutaminazo
Charriere et al. Reactions to a bovine collagen implant: Clinical and immunologic study in 705 patients
Jackson et al. Dynamic characteristics of gastrin release
KR910002897A (ko) 에리트로포이에틴(epo)펩타이드 및 이에 대한 항체
Arbuckle et al. Shared Early Autoantibody Recognition Events in the Development of Anti‐Sm B/B'in Human Lupus
DK0536275T3 (da) Tumorvækstinhibitorer udledt fra væv, fremgangsmåde til deres fremstilling samt anvendelse heraf
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
Fraquelli et al. Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease
US20030049691A1 (en) Allergenic proteins and peptides from dog dander and uses therefor
EP1196450B1 (fr) Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumato de
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
SI0998556T1 (en) Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
EP0640101B1 (en) Methods and reagents for diagnosis of autoantibodies
Waxman et al. The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitis
Tremaine et al. Bismuth subsalicylate tablets for chronic antibiotic-resistant pouchitis
BR0308095A (pt) Teste para anticorpos anti-ingap
IL120503A0 (en) Peptides for the treatment of systemic lupus erythematosis and pharmaceutical compositions containing them
BR9909308A (pt) Peptìdeo, ensaio para o diagnóstico de esquizofrenia em um indivìduo, e, kit para uso no diagnóstico de esquizofrenia
Takahashi et al. Drug-induced inhibition of insulin recognition by T-cells: the antirheumatic drug aurothiomalate inhibits MHC binding of insulin peptide
CA2251058A1 (en) Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone h1
Cusi et al. Peripheral neuropathy associated with anti-myelin basic protein antibodies in a woman vaccinated with rubella virus vaccine
Otley et al. The pathogenesis of dermatitis herpetiformis
Adam et al. Rheumatoid arthritis and collagen antibodies
Tran et al. The trefoil peptide TFF-2 potently accelerates healing in a rat model of inflammatory bowel disease
Szelényi et al. Immunomodulatory effect and acetylcholine receptor binding of a thymopeptide (Tp4) on human peripheral blood lymphocytes

Legal Events

Date Code Title Description
IF Valid on the event date